Skip to main content
رجوع
Watch Compare

BioScience Health Innovations, Inc.

جودة البيانات: 100%
BHIC
OTC Technology Cloud & Data Services
KWD 2.15
▼ KWD 0.06 (-2.71%)
القيمة السوقية: 24.44 M
السعر
KWD 2.15
القيمة السوقية
24.44 M
نطاق اليوم
KWD 2.15 — KWD 2.15
نطاق 52 أسبوعًا
KWD 0.52 — KWD 52.00
حجم التداول
300
فتح KWD 2.15
متوسط 50 يوم / 200 يوم
KWD 3.48
38.17% below
متوسط 50 يوم / 200 يوم
KWD 7.23
70.26% below

Quick Summary

النقاط الرئيسية

Earnings grew 638.03% over the past year
ROE of 37.43% indicates high profitability
Generating 172,178.0 in free cash flow
P/E of 38.06 — premium valuation
ROIC of 27.55% — excellent capital efficiency

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)208.34%
Earnings (1Y)638.03%
FCF Growth (3Y)N/A

الجودة

Return on Equity
37.43%
أعلى من متوسط القطاع (1.81%)
ROIC27.55%
Net Margin11.29%
Op. Margin12.64%

الأمان

Debt / Equity
N/A
Current RatioN/A
Interest CoverageN/A

التقييم

PE (TTM)
38.06
أعلى من متوسط القطاع (-0.15)
P/B Ratio14.28
EV/EBITDA32.40
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Technology (1058 نظير)
المقياس السهم وسيط القطاع
P/E 38.1 -0.1
P/B 14.3 3.0
ROE % 37.4 1.8
Net Margin % 11.3 -0.5
Rev Growth 5Y % — 7.2
D/E — 0.4

All Fundamental Metrics
Growth
Revenue Growth (1Y) 208.34% Revenue Growth (3Y) 208.53%
Earnings Growth (1Y) 638.03% Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 5.69 M Net Income (TTM) 642,090.0
ROE 37.43% ROA 31.14%
Gross Margin 56.97% Operating Margin 12.64%
Net Margin 11.29% Free Cash Flow (TTM) 172,178.0
ROIC 27.55% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio N/A
Interest Coverage N/A Asset Turnover 2.76
Working Capital N/A Tangible Book Value 1.64 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 38.06 Forward P/E N/A
P/B Ratio 14.28 P/S Ratio 4.30
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 32.40 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 0.70%
Market Cap 24.44 M Enterprise Value 23.30 M
Per Share
EPS (Diluted TTM) 0.06 Revenue / Share 0.50
FCF / Share 0.02 OCF / Share 0.02
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 26.82%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 5.69 M 1.84 M 597,595.0 0.0 0.0
Net Income 642,090.0 87,000.0 -251,500.0 -83,208.0 -25,610.0
EPS (Diluted) 0.06 0.00 — — —
Gross Profit 3.24 M 1.31 M 484,407.0 — —
Operating Income 719,051.0 87,000.0 -251,500.0 -91,921.0 -25,610.0
EBITDA — — — — —
R&D Expenses 161,353.0 25,908.0 — — —
SG&A Expenses 2.21 M 1.15 M 706,257.0 91,921.0 25,610.0
D&A — — — — —
Interest Expense — — — 450.0 450.0
Income Tax 76,961.0 0.0 0.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 1.71 M 873,788.0 93,388.0 16,253.0 6,314.0
Total Liabilities 229,851.0 38,548.0 100,148.0 1,860.0 19,106.0
Shareholders' Equity 1.48 M 835,240.0 -6,760.0 14,393.0 -12,792.0
Total Debt — — — — —
Cash & Equivalents 661,925.0 662,517.0 19,238.0 — 2,035.0
Current Assets 1.56 M 847,751.0 93,388.0 16,253.0 6,314.0
Current Liabilities — — — — —